Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
11,821 Dovepress* 9,775 626+ 2,933 10,401
PubMed Central* 1 1,419 1,376 1,420
Totals 9,776 2,045 4,309 11,821
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar